Drug profile · INN
asenapine
SYCREST
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
asenapine (SYCREST) is an FDA-listed pharmaceutical active ingredient. Route of administration: transdermal. Current US regulatory status: approved.
Key facts
INN asenapine
Brand SYCREST
Route TRANSDERMAL
Formulation SYSTEM
ATC code N05AH05
Frequently asked questions
What is asenapine?
asenapine (SYCREST) is an FDA-listed pharmaceutical active ingredient. Route of administration: transdermal. Current US regulatory status: approved.
What is the brand name for asenapine?
SYCREST is a marketed brand name for asenapine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of asenapine?
asenapine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.